84.1% of participants in the first study, 89.5% of participants in the second, and 88.9% of participants in the third were within normal blood sugar ranges after taking semaglutide for 68 weeks
Participants randomized to retatrutide initiated treatment with 2 mg once weekly and increased the dose in a stepwise approach every four weeks until reaching the target dose of 9 mg (via steps at 2 mg, 4 mg, and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg, and 9 mg)
Saxenda 6 mg/mL solution for injection in pre-filled pen (SmPC)
Your role in this process is as important as that of your healthcare team
Given the variability in individual responses to antioxidants, future research should focus on personalized approaches to antioxidant therapy
Many patients prefer dosing on a weekend morning so any initial side effects happen when work and obligations are minimal